R
RocRock Biotechnology
Developer of genetic editing, biomaterials, and treatment for solid tumors platforms
About RocRock Biotechnology
RocRock Biotechnology is a pioneering company in China specializing in macrophage drug therapy for solid tumors. Utilizing advanced gene editing, biomaterials, and synthetic biology, the company has developed four core technology platforms to address significant challenges in macrophage research and application. These platforms aim to overcome issues such as the difficulty and high cost of in vitro macrophage culture, long culture cycles, and challenges in macrophage gene transduction. RocRock Biotechnology serves the medical and pharmaceutical sectors, focusing on innovative treatments for cancer patients. The company operates in the biotechnology market and employs a business model centered around the development and clinical application of its proprietary technologies. Revenue is generated through partnerships, clinical trials, and eventual commercialization of its therapies.
Source: Dealroom company dataAt a glance
- Founded
- 2021
- Headquarters
- Ningbo, China
- Sector
- Biotech & Life Sciences
News
Open roles
RocRock Biotechnology in the Ningbo ecosystem
The RocRock Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
- LCLiman Caixiang
- AVASB Ventures
- JMJiaxing Deshi Private Equity Fund Management
- QMQingdao Guozhu Asset Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about RocRock Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RocRock Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
